Drug Eluting Stent Market Analysis, By Coating (Polymer based Coating, Polymer free coating), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End use (Hospitals, Cardiology centres, Ambulatory Surgical Centres), Forecasts to 2026
<b>Ask for Sample/Enquiry and details report @ WMR</b>
<b><a href= “https://westernmarketresearch.com/sample-report/339858/Drug Eluting Stent Market Analysis, By C#sample”>https://westernmarketresearch.com/sample-report/339858/Drug Eluting Stent Market Analysis, By C#sample</a></b>
WMR-Western Market Research has recently published a comprehensive and exclusive research report, which is an intelligent study covering all key segments. This research report provides breakthrough inputs and insights on market related factors like size, competition, trends, analysis, forecasts etc. The study encompasses primary and secondary data sources along with quantitative and qualitative practices thus assuring data accuracy.
The global drug eluting stent market size was valued at USD 5.63 Billion in 2018 and is expected to reach USD 8.74 Billion by year 2026, at a CAGR of 5.67%. The development of stents has been a major advancement in the treatment of obstructive coronary artery disease since the introduction of balloon angioplasty. Stents are small mesh tubes inserted to keep arteries open after a procedure called angioplasty (percutaneous coronary intervention or PCI). Drug eluting stents (DES) have a polymer coating over mesh that emits a drug over time to help keep the blockage from coming back. These stents were introduced primarily to overcome the problem of late restenosis that was prevalent at an excessively high rate with bare-metal stents. Since the arrival of DES, restenosis figures have dropped to a single digit, even for the most complex lesions. Number of companies in the global drug eluting stent market are engaged in the launch of new DES devices.There global drug eluting stent market trends in the report consider different strategic developments such as agreement and product development in the analysis. For instance, companies such as Biosensors and Abbott are developing biodegradable and bifurcated stents to deal with concerns about thrombosis caused by long-term device implantation and to expand the type of treatable lesions, including those located at vessel branches. The global DES market is propelled by number of factors such as rise in the geriatric population, increasing prevalence of cardiovascular diseases, growing acceptance for minimally invasive endovascular surgeries. New product developments in DES, such as biodegradable materials and bifurcated stents, are expected to prompt an increase in market value during the forecast period in the drug eluting stent market.The companies considered in DES market analysis include, Terumo Corporation, Biosensors, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Biotronik SE & Co. KG, and MicroPort Scientific CorporationPolymer based Coating, Polymer free coating,Coronary Artery Disease, Peripheral Artery Disease,Hospitals, Cardiology centres, Ambulatory Surgical Centres
<b>Click to know more about product @ WMR</b>
<b><a href= “https://westernmarketresearch.com/market-report/339858/Drug Eluting Stent Market Analysis, By C”>https://westernmarketresearch.com/market-report/339858/Drug Eluting Stent Market Analysis, By C</a></b>